Your browser doesn't support javascript.
loading
Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer.
Yao, Wantong; Rose, Johnathon L; Wang, Wei; Seth, Sahil; Jiang, Hong; Taguchi, Ayumu; Liu, Jintan; Yan, Liang; Kapoor, Avnish; Hou, Pingping; Chen, Ziheng; Wang, Qiuyun; Nezi, Luigi; Xu, Zhaohui; Yao, Jun; Hu, Baoli; Pettazzoni, Piergiorgio F; Ho, I Lin; Feng, Ningping; Ramamoorthy, Vandhana; Jiang, Shan; Deng, Pingna; Ma, Grace J; Den, Peter; Tan, Zhi; Zhang, Shu Xing; Wang, Huamin; Wang, Y Alan; Deem, Angela K; Fleming, Jason B; Carugo, Alessandro; Heffernan, Timothy P; Maitra, Anirban; Viale, Andrea; Ying, Haoqiang; Hanash, Samir; DePinho, Ronald A; Draetta, Giulio F.
Afiliação
  • Yao W; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rose JL; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang W; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Seth S; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jiang H; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Taguchi A; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Liu J; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Yan L; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kapoor A; Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hou P; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chen Z; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang Q; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Nezi L; Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Xu Z; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Yao J; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hu B; Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pettazzoni PF; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ho IL; Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Feng N; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ramamoorthy V; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jiang S; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Deng P; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ma GJ; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Den P; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tan Z; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zhang SX; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang H; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang YA; Department of Experimental Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Deem AK; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Fleming JB; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Carugo A; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Heffernan TP; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Maitra A; Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Viale A; Department of Gastrointestinal Oncology, Moffitt Cancer Center, Tampa, FL, USA.
  • Ying H; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hanash S; Center for Co-Clinical Trials, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • DePinho RA; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Draetta GF; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nature ; 568(7752): 410-414, 2019 04.
Article em En | MEDLINE | ID: mdl-30918400
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Pinocitose / Carcinoma Ductal Pancreático / Sindecana-1 Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Nature Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Pinocitose / Carcinoma Ductal Pancreático / Sindecana-1 Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Nature Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos